PharmacoEconomics & Outcomes News 792, p8 - 2 Dec 2017 Cost of Ebola prevention substantial in Netherlands The costs of prevention of Ebola virus disease (EVD) appear to be substantial in the Netherlands, according to findings of a study published in the European Journal of Health Economics. During the Ebola epidemic in African countries between December 2013 and April 2016, the Dutch National Institute for Public Health and the Environment (RIVM) was appointed national EVD coordinator in the Netherlands, with general practitioners (GPs) and emergency departments at 80 peripheral hospitals as first responders, and referral of suspected cases to one of eight academic hospitals with transportation by 25 regional ambulance services, and diagnosis by one laboratory. In addition, 25 Municipal Health Services managed regional public health activities. An activity-based costing method was used to estimate costs of Ebola preparedness and response from the perspective of the Dutch healthcare system, based on a time-recording system, interviews with key professionals at healthcare organisations, and cost data on hospitalisation, laboratory tests, personal protective equipment (PPE), and cleaning and disinfection. During the epidemic period, Dutch healthcare professionals consulted the RIVM about possible Ebola cases 89 times, 13 possible cases of Ebola were clinically evaluated at academic hospitals, and one confirmed case (a United Nation employee working in Africa) was hospitalised. Estimated total costs of Ebola preparedness and response in the Netherlands ranged from €6.7 million to €22.5 million (mean €12.6 million). The primary cost drivers were PPE expenditure and preparedness activities, particularly those associated with ambulance services and hospitals. Mean costs were $1.06 million for GPs, €1.48 million for ambulance services, €4.77 million for hospitals, €0.25 million for the virological laboratory, €1.23 million for Municipal Health Services and €0.23 million for the RIVM. "Designating one ambulance service and just a few hospitals for the transportation and admission of patients with suspected viral hemorrhagic fever or other highly infectious disease might improve efficiency and reduce future costs," commented the authors. * 2015 euros Suijkerbuijk AWM, et al. Ebola in the Netherlands, 2014-2015: costs of preparedness and response. European Journal of Health Economics : 17 Nov 2017. Available from: URL: https://doi.org/10.1007/s10198-017-0940-4 803285956 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792
PharmacoEconomics & Outcomes News – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera